Colman RJ, Xiong Y, Mizuno T, Hyams JS, et al. Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Aliment Pharmacol Ther 2022;55:593-603.
PMID: 34935161